CYBERDYNE Inc. (CYBQF)
OTCMKTS
· Delayed Price · Currency is USD
1.300
0.00 (0.00%)
At close: Mar 20, 2025
CYBERDYNE Revenue
In the fiscal year ending March 31, 2025, CYBERDYNE had annual revenue of 4.38B JPY with 0.69% growth. CYBERDYNE had revenue of 1.22B in the quarter ending March 31, 2025, with 7.05% growth.
Revenue
4.38B JPY
Revenue Growth
+0.69%
P/S Ratio
8.66
Revenue / Employee
19.31M JPY
Employees
227
Market Cap
253.55M USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 4.38B | 30.00M | 0.69% |
Mar 31, 2024 | 4.35B | 1.07B | 32.38% |
Mar 31, 2023 | 3.29B | 1.14B | 52.98% |
Mar 31, 2022 | 2.15B | 275.00M | 14.67% |
Mar 31, 2021 | 1.88B | 83.00M | 4.63% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |